No Data
No Data
Bloomage Biotechnology Corporation Limited (688363.SH) has repurchased a total of 3.3155 million shares, costing 220 million yuan.
Bloomage Biotechnology Corporation Limited (688363.SH) announced that as of June 28, 2024, the company has cumulatively repurchased company shares...
Bloomage BioTechnology Corporation Limited's (SHSE:688363) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?
Bloomage BioTechnology (SHSE:688363) has had a rough month with its share price down 3.6%. However, a closer look at its sound financials might cause you to think again. Given that fundamentals usua
CITIC Securities: the collagen industry's prosperity continues with significant growth among various leading companies, and there is ample potential for the future.
According to the Zhitong Finance APP, Citic Securities research report believes that the sales of restructured collagen products have been excellent, with brands such as Weweima, Kelifu, and Viyimi performing well this year.
As of May 31st, 2024, there were 35,186 shareholders in Bloomage Biotechnology Corporation Limited (688363.SH).
Bloomage Biotechnology Corporation Limited (688363.SH) stated on the investor interaction platform on June 4th that as of May 31, 2024, the number of shareholders in the company was 35,186.
Here's Why Bloomage BioTechnology (SHSE:688363) Can Manage Its Debt Responsibly
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility of prices, but whether you will suffer a permanent loss of capital.' It's only n
Huaxi Biotech (688363.SH): The company's medical and aesthetic business developed well in the first quarter and maintained rapid growth
Gelonghui, May 24 | Huaxi Biotech (688363.SH) said on the investor interactive platform that the company's medical and aesthetic business developed well in the first quarter of 2024 and still maintained rapid growth.
No Data